Hebei New Century Pharmaceutical Co., Ltd.

home products Liquid Injection Sulfadiazine40% + Trimethoprim 8% Injection

Sulfadiazine40% + Trimethoprim 8% Injection

Product Details:

Type Drug
Dosage Form Injection
Component Sulfadiazine,TMP
Drug Form Injection
Function Antibiotic
Place of Origin Hebei, China (Mainland)
Brand Name Ji Xin
Model Number Sulfadiazine40%+Trimethoprim8%

Payment & Shipping Terms:

Minimum Order Quantity: 500 Piece/Pieces
Price: FOB TIANJIN USD 0~10
Packaging Details: 50ML,100ML
Delivery Time: WITH IN 30 DAYS AFTER WE CONFIRMED THE PACKING
Payment Terms: L/C,T/T
Supply Ability: 5000 Piece/Pieces per Day

Detailed Product Description


Detailed product description:
Composition:
Sulfadiazine (40%) + Trimethoprim (8%)
INDICATIONS:

Indicated in the treatment of wide range of diseases of bacterial origin.Particularly effective in the infectious respiratory,urogenital and alimentary tracts. 

The combination of Sulfadiazine Sodium and Trimethoprim acts synergistic and usually bactericidal against many Gram-positive and Gram-negative bacteria like E. coli, Haemophilus, Pasteurella, Salmonella, Staphylococcus and Streptococcus spp. Treatment of gastrointestinal, respiratory and urinary tract infections caused by TMP and Sulfadiazine sensitive bacteria in horse, foal, calves, cattle, pig.

Side effects:

occasionally, temporary swelling at injection sites may occur

Withdrawal periods:

For meat: 12 days, For milk: 4 days

STORAGE:

in a cool ,dry place,protect from light.

TERM OF VALIDITY:

3years

PACKAGE:

100ML,50ML

Sulfadiazine40% + Trimethoprim 8%  Injection Sulfadiazine40% + Trimethoprim 8% Injection

Send your message to this supplier
« Prev Product 1 2 3 4 5 6 7 ... Next Product »

Other Products from this Supplier

Company Info

Hebei New Century Pharmaceutical Co., Ltd.
[China (Mainland)]
[Verified Member]

City: Shijiazhuang
Province/State: Hebei
Country/Region : China (Mainland)

Business Type:Manufacturer, Trading Company

View Contact Details

Email this page Bookmark this page Print this Page